
Production of generic medicines and health products, primarily manufactured in France and Europe.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Pharma & Beauty Group
B
Development and production of formulas for the health and beauty sectors, including advanced manufacturing facilities in France.
LFB
B
Development, manufacturing, and commercialization of plasma-derived biomedicines. Focus on public health and French health sovereignty.
Laboratoire Osalia
B
Production of generic veterinary medicines, including antibiotics, anti-inflammatory drugs, and other treatments for various animal species.
Initiatives identified among leaders
Participation à des événements pour promouvoir la santé et la sécurité des patients
“LFB participe à des événements pour promouvoir la ...” - LFBCulture de l'inclusivité et de la diversité
“Laboratoire Osalia développe une culture de l'incl...” - Laboratoire OsaliaCharte RSE
“LFB a créé une Charte RSE avec 10 engagements, pou...” - LFB66% of similar organizations communicate on CSR issues
+1815 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports